F2 Bioscience I 2017 Ltd - 10%+ Owner at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
CGEM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by F2 Bioscience I 2017 Ltd since 12 Feb 2025

Holdings reported by F2 Bioscience I 2017 Ltd for Cullinan Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,305,873 $16,271,178 $12.46 21 Jun 2022 F2 Vision SCS
Common Stock 1,136,525 $14,161,102 $12.46 21 Jun 2022 By Globeways Holdings Ltd.
Common Stock 622,175 $7,752,301 $12.46 21 Jun 2022 By F2-TPO Investments, LLC
Common Stock 537,392 $6,695,904 $12.46 23 Jun 2022 Direct
Common Stock 325,333 $4,053,649 $12.46 21 Jun 2022 By F2 MG Ltd.
Common Stock 214,798 $2,676,383 $12.46 21 Jun 2022 By F2 MC, LLC
Common Stock 112,507 $1,401,837 $12.46 21 Jun 2022 By Morana Jovan-Embiricos
Common Stock 104,762 $1,305,335 $12.46 21 Jun 2022 By F2 GC, LLC
Common Stock 71,599 $892,124 $12.46 21 Jun 2022 By F2 Bio TD, LLC

Transactions reported by F2 Bioscience I 2017 Ltd for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.